12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
Clinical trial NCT02015234 · COMPLETED
Trial details
- NCT number
- NCT02015234
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-08-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.